文献速递免疫规划传染病防控与疫情报告

年度接种是否最佳?儿童流感疫苗接种策略的建模研究

Is annual vaccination best? A modelling study of influenza vaccination strategies in children.
PubMed 文献 · Vaccine · 2022-04-08

该建模研究以英国为背景,构建多年度、个体随机感染压力模型,模拟出生队列至18岁,比较年度接种、每两年接种和不接种对儿童感染率与感染数的影响。基线接种覆盖率44%下,年度接种的感染数少于每两年接种和不接种,但年度与每两年接种的差异较小;引入重复暴露惩罚后差异进一步缩小。

要点

  • 年度接种比每两年接种和不接种减少更多儿童感染,但年度与每两年接种差异较小。
  • 基线假设接种覆盖率44%时,0-18岁平均感染数年度接种为2.07,每两年接种为2.38,不接种为2.63。
  • 引入重复暴露惩罚后,每两年接种与年度接种的感染数差异从0.31降至0.04。

核心结论

  • 年度接种比每两年接种减少更多儿童感染,但差异较小;即使接种覆盖率不高,年度接种仍有价值,但实施每两年接种方案也可能获得相似收益。

研究设计与样本

  • 多年度、个体随机、感染压力模型,模拟出生队列经历年度流感流行并随访至18岁。
  • 基线模拟假设接种覆盖率为44%,比较年度接种与不接种及每两年接种。

主要发现

  • 基线时,在至少一半时间接种的儿童中,年度接种在2至10岁期间的感染数不到不接种的一半。
  • 0-18岁平均感染数:年度接种2.07(2.06,2.08),不接种2.63(2.62,2.64),每两年接种2.38(2.37,2.40)。
  • 引入重复暴露惩罚后,每两年接种与年度接种的儿童感染数差异从0.31降至0.04。

关键数值与推荐

  • 基线接种覆盖率假设为44%。
  • 0-18岁平均感染数:年度接种2.07(2.06,2.08),不接种2.63(2.62,2.64),每两年接种2.38(2.37,2.40)。
  • 至少一半时间接种的儿童中,年度接种在2至10岁感染数不到不接种的一半。
  • 重复暴露惩罚增加时,每两年接种与年度接种的感染数差异从0.31降至0.04。

临床怎么用

  • 作者认为,研究结果确认了儿童年度接种的价值,即使接种覆盖率不高。
  • 作者指出,实施每两年接种方案也可能获得相似收益,尤其当重复接种存在负面效应时。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Annual vaccination of children against influenza is a key component of vaccination programs in many countries. However, past infection and vaccination may affect an individual's susceptibility to infection. Little research has evaluated whether annual vaccination is the best strategy. Using the United Kingdom as our motivating example, we developed a framework to assess the impact of different childhood vaccination strategies, specifically annual and biennial (every other year), on attack rate and expected number of infections. METHODS AND FINDINGS: We present a multi-annual, individual-based, stochastic, force of infection model that accounts for individual exposure histories and disease/vaccine dynamics influencing susceptibility. We simulate birth cohorts that experience yearly influenza epidemics and follow them until age 18 to determine attack rates and the number of infections during childhood. We perform simulations under baseline conditions, with an assumed vaccination coverage of 44%, to compare annual vaccination to no and biennial vaccination. We relax our baseline assumptions to explore how our model assumptions impact vaccination program performance. At baseline, we observed less than half the number of infections between the ages 2 and 10 under annual vaccination in children who had been vaccinated at least half the time compared to no vaccination. When averaged over all ages 0-18, the number of infections under annual vaccination was 2.07 (2.06, 2.08) compared to 2.63 (2.62, 2.64) under no vaccination, and 2.38 (2.37, 2.40) under biennial vaccination. When we introduced a penalty for repeated exposures, we observed a decrease in the difference in infections between the vaccination strategies. Specifically, the difference in childhood infections under biennial compared to annual vaccination decreased from 0.31 to 0.04 as exposure penalty increased. CONCLUSION: Our results indicate that while annual vaccination averts more childhood infections than biennial vaccination, this difference is small. Our work confirms the value of annual vaccination in children, even with modest vaccination coverage, but also shows that similar benefits of vaccination may be obtained by implementing a biennial vaccination program. AUTHOR SUMMARY: Many countries include annual vaccination of children against influenza in their vaccination programs. In the United Kingdom (UK), annual vaccination of children aged of 2 to 10 against influenza is recommended. However, little research has evaluated whether annual vaccination is the best strategy, while accounting for how past infection and vaccination may affect an individual's susceptibility to infection in the current influenza season. Prior work has suggested that there may be a negative effect of repeated vaccination. In this work we developed a stochastic, individual-based model to assess the impact of repeated vaccination strategies on childhood infections. Specifically, we first compare annual vaccination to no vaccination and then annual vaccination to biennial (every other year) vaccination. We use the UK as our motivating example. We found that an annual vaccination strategy resulted in the fewest childhood infections, followed by biennial vaccination. The difference in number of childhood infections between the different vaccination strategies decreased when we introduced a penalty for repeated exposures. Our work confirms the value of annual vaccination in children, but also shows that similar benefits of vaccination can be obtained by implementing a biennial vaccination program, particularly when there is a negative effect of repeated vaccinations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ainslie KEC, Riley S. Is annual vaccination best? A modelling study of influenza vaccination strategies in children. Vaccine. 2022. PMID: 35410816. doi:10.1016/j.vaccine.2022.03.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。